NeuroOne Medical Technologies Corporation (NMTC) Earnings History
Net Loss16 years of earnings data (2010–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
NeuroOne Medical Technologies Corporation (NMTC) Earnings Overview
As of June 30, 2026, NeuroOne Medical Technologies Corporation (NMTC) reported trailing twelve-month net income of -$7M, reflecting +80.4% year-over-year growth. The company earned $-0.78 per diluted share over the past four quarters, with a net profit margin of -29.8%.
Looking at the long-term picture, NMTC's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6,044 in fiscal 2010.
NeuroOne Medical Technologies Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including LIVN ($107M net income, -17.5% margin), NVCR (-$173M net income, -20.8% margin), MDT ($4.80B net income, 13.2% margin), NMTC has room to improve margins relative to the peer group. Compare NMTC vs LIVN →
NMTC Earnings vs Peers
Earnings metrics vs comparable public companies
NMTC Historical Earnings Data (2010–2025)
16 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$4M | +70.7% | -$4M | $-0.54 | -29.8% | -34.9% |
| 2024 | -$12M | -3.9% | -$12M | $-2.76 | -356.7% | -344.3% |
| 2023 | -$12M | -18.6% | -$12M | $-3.90 | -607.4% | -612.3% |
| 2022 | -$10M | -0.5% | -$10M | $-3.78 | -5842.0% | -5860.2% |
| 2021 | -$10M | +27.1% | -$10M | $-5.58 | -5584.3% | -5735.9% |
| 2020 | -$14M | -101.1% | -$5M | $-15.12 | -708.0% | -254.5% |
| 2019 | -$7M | +0.7% | -$6M | $-10.32 | - | - |
| 2018 | -$7M | -35.0% | -$3M | $-14.58 | - | - |
| 2017 | -$5M | -10488.0% | -$3M | $-13.80 | - | - |
| 2016 | $-47,775 | +24.0% | $-32,611 | $-0.17 | - | - |
| 2015 | $-62,863 | -73.4% | $-30,915 | $-0.22 | -8472.1% | -4166.4% |
| 2014 | $-36,244 | -18.6% | $-35,914 | $-0.13 | -4688.7% | -4646.1% |
| 2013 | $-30,554 | -118.9% | $-19,632 | $-0.11 | -2446.3% | -1571.8% |
| 2012 | $-13,960 | +49.4% | $-13,733 | $-0.05 | -1515.7% | -1491.1% |
| 2011 | $-27,604 | -356.7% | $-27,428 | $-0.11 | -511.4% | -508.1% |
| 2010 | $-6,044 | - | $-6,044 | $-0.03 | -517.9% | -517.9% |
Download Data
Export NMTC earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
16+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NMTC — Frequently Asked Questions
Quick answers to the most common questions about buying NMTC stock.
What is NMTC earnings per share (EPS)?
NMTC trailing twelve-month (TTM) diluted EPS is $-0.78, reflecting +80.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2010 to 2025 is available in the table on this page.
What is NeuroOne Medical Technologies Corporation's net income?
NeuroOne Medical Technologies Corporation (NMTC) trailing twelve-month net income is $-7M as of 2025. Earnings grew +80.4% year-over-year.
Is NMTC profitable?
NMTC is not currently profitable on a TTM basis, reporting a net loss of $-7M. Net margin is -29.8%. Investors should monitor for a return to profitability.
What is NMTC's earnings growth rate?
NMTC compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2010 to 2025.
What are NMTC's profit margins?
NeuroOne Medical Technologies Corporation net profit margin is -29.8%, operating margin is -34.9%, and gross margin is +67.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is -91.3%.
Is NMTC growing earnings?
Yes, NMTC earnings are accelerating — EPS growth of +80.4% exceeds the 5-year CAGR of N/A. TTM net income reached $-7M. Earnings momentum is strengthening.
What was NMTC's best earnings year?
NeuroOne Medical Technologies Corporation's highest annual net income on record is $-6044.00, achieved in fiscal year 2010. Earnings history on this page spans 2010 to 2025 and includes all annual and quarterly figures.
What were NMTC's earnings last quarter?
NMTC's most recent reported quarter was Q2 2026. Net income was $-2M with diluted EPS of $-0.25. For a full breakdown of all quarters, see the quarterly earnings table on this page.